Carlet Jean, Ben Ali Adel, Chalfine Annie
Intensive Care Unit, Fondation Hôpital Saint-Joseph, 185, rue Raymond Losserand, 75014 Paris, France.
Curr Opin Infect Dis. 2004 Aug;17(4):309-16. doi: 10.1097/01.qco.0000136927.29802.68.
Resistance to antibiotics is very high in the intensive care units of many countries, although there are several exceptions. Some infections are becoming extremely difficult to treat. The risk of cross-transmission of those strains is very high. This review focuses on recent data (2003 to the present) that may help understanding and dealing with this serious public health problem.
Intensive care units can be considered as 'factories' for creating, disseminating and amplifying resistance to antibiotics, for many reasons: importation of resistant microorganisms at admission, selection of resistant strains with an extensive use of broad-spectrum antibiotics, cross-transmission of resistant strains via the hands or the environment. Some national programs can be considered as failures, as in the UK and the USA. Other countries have been able to maintain a low level of resistance (Scandinavian countries, Netherlands, Switzerland, Germany, Canada). There is clearly an 'inoculum effect' above which preventive measures become poorly efficient. Several preventive measures have been proposed including preventive isolation, systematic screening at admission, local, national or international antibiotic guidelines, antibiotic prescriptions advice by infectious-disease teams, antibiotic prevention with selective digestive decontamination, antibiotic strategies such as 'cycling', or rather, for some authors, the use of an 'à la carte' antibiotic strategy which could be considered as a 'patient-to-patient antibiotic rotation'.
There is obviously an international concern regarding the level of resistance to antibiotics in the intensive-care-unit setting. A strong program including prevention of cross-transmission and better usage of antibiotics seems to be needed in order to be successful. We do not know if this kind of program will enable countries with a very high endemic level of resistance to decrease the level in future years.
在许多国家的重症监护病房中,抗生素耐药性非常高,不过也有一些例外情况。某些感染正变得极难治疗。这些菌株的交叉传播风险非常高。本综述聚焦于近期数据(2003年至今),这些数据可能有助于理解和应对这一严重的公共卫生问题。
出于多种原因,重症监护病房可被视为产生、传播和放大抗生素耐药性的“工厂”:入院时耐药微生物的输入、广泛使用广谱抗生素导致耐药菌株的选择、耐药菌株通过手部或环境的交叉传播。一些国家项目可被视为失败案例,如英国和美国。其他国家则能够维持较低的耐药水平(斯堪的纳维亚国家、荷兰、瑞士、德国、加拿大)。显然存在一种“接种效应”,超过这一效应,预防措施的效果就会大打折扣。已经提出了多种预防措施,包括预防性隔离、入院时的系统筛查、地方、国家或国际抗生素指南、感染病团队的抗生素处方建议、选择性消化道去污的抗生素预防、“轮换”等抗生素策略,或者,对于一些作者而言,使用“点菜式”抗生素策略,这可被视为“患者间抗生素轮换”。
显然,国际社会对抗重症监护病房环境中抗生素耐药性的水平表示关注。若要取得成功,似乎需要一个强有力的项目,包括预防交叉传播和更好地使用抗生素。我们不知道这类项目是否能使耐药性地方流行水平非常高的国家在未来几年降低这一水平。